RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism.
We have generated RANK (receptor activator of NF-kappaB) nullizygous mice to determine the molecular genetic interactions between osteoprotegerin, osteoprotegerin ligand, and RANK during bone resorption and remodeling processes. RANK(-/-) mice lack osteoclasts and have a profound defect in bone resorption and remodeling and in the development of the cartilaginous growth plates of endochondral bone. The osteopetrosis observed in these mice can be reversed by transplantation of bone marrow from rag1(-/-) (recombinase activating gene 1) mice, indicating that RANK(-/-) mice have an intrinsic defect in osteoclast function. Calciotropic hormones and proresorptive cytokines that are known to induce bone resorption in mice and human were administered to RANK(-/-) mice without inducing hypercalcemia, although tumor necrosis factor alpha treatment leads to the rare appearance of osteoclast-like cells near the site of injection. Osteoclastogenesis can be initiated in RANK(-/-) mice by transfer of the RANK cDNA back into hematopoietic precursors, suggesting a means to critically evaluate RANK structural features required for bone resorption. Together these data indicate that RANK is the intrinsic cell surface determinant that mediates osteoprotegerin ligand effects on bone resorption and remodeling as well as the physiological and pathological effects of calciotropic hormones and proresorptive cytokines.
Li
J
J
Departments of Cell Biology, Amgen Inc., One Amgen Center Drive, Thousand Oaks, CA 91320, USA.
Sarosi
I
I
Yan
X Q
XQ
Morony
S
S
Capparelli
C
C
Tan
H L
HL
McCabe
S
S
Elliott
R
R
Scully
S
S
Van
G
G
Kaufman
S
S
Juan
S C
SC
Sun
Y
Y
Tarpley
J
J
Martin
L
L
Christensen
K
K
McCabe
J
J
Kostenuik
P
P
Hsu
H
H
Fletcher
F
F
Dunstan
C R
CR
Lacey
D L
DL
Boyle
W J
WJ
D000818:Animals; D016723:Bone Remodeling / Q000235:genetics; D001862:Bone Resorption / Q000235:genetics; D001842:Bone and Bones / Q000378:metabolism*; D002118:Calcium / Q000378:metabolism*; D002352:Carrier Proteins / Q000235:genetics* / Q000378:metabolism / Q000494:pharmacology; D002454:Cell Differentiation / Q000235:genetics; D016207:Cytokines / Q000494:pharmacology; D018390:Gene Targeting; D018014:Gene Transfer Techniques; D006132:Growth Plate / Q000473:pathology; D008562:Membrane Glycoproteins / Q000235:genetics* / Q000378:metabolism / Q000494:pharmacology; D051379:Mice; D018345:Mice, Knockout; D010010:Osteoclasts / Q000473:pathology; D010012:Osteogenesis; D010022:Osteopetrosis / Q000235:genetics / Q000473:pathology; D053245:RANK Ligand; D053246:Receptor Activator of Nuclear Factor-kappa B; D012190:Retroviridae / Q000235:genetics
D002352:Carrier Proteins; D016207:Cytokines; D008562:Membrane Glycoproteins; D053245:RANK Ligand; D053246:Receptor Activator of Nuclear Factor-kappa B; C505686:TNFRSF11A protein, human; C505688:TNFSF11 protein, human; C505687:Tnfrsf11a protein, mouse; C505689:Tnfsf11 protein, mouse; D002118:Calcium